SEC Form 4 · accession 0001250853-15-000023
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Chin
Officer — President and CEO · Director · 10% Owner
Period of report
Feb 5, 2015
Accepted (ET)
Feb 6, 2015 · 8:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $6.45 | Feb 5, 2015 | A | 197,771 | A | — | Feb 5, 2025 | Common Stock | 197,771 | 197,771 | D |
Explanation of responses
- F1The option will vest as to 25% after one year following the date of grant, and the remainder will vest in equal monthly installments over the following three years.